BSE filing, NSE: KPL. Summary written from the filing by ALFA Finder's alert engine.
Kwality Pharmaceuticals Ltd: key numbers
- Share price
- ₹3,689.65
- Market cap
- ₹3,828 Cr
- Revenue (annual)
- ₹503.1 Cr
- Net profit (annual)
- ₹67.35 Cr
- P/E (TTM)
- 47.2×Sector 42.0×
- Promoter holding
- 54.86%+0.00% QoQ
- FII holding
- 2.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kwality Pharmaceuticals Ltd
All →Kwality Pharmaceuticals Business Update
Kwality Pharmaceuticals secured EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities. This expands its EU-approved manufacturing footprint and positions it for global licensing opportunities.
Kwality Pharmaceuticals Other Announcement
Kwality Pharmaceuticals Ltd filed its shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Kwality Pharmaceuticals Capacity Expansion
Kwality Pharmaceuticals acquired 4 acres adjacent to its Amritsar plant to build a fully automated facility with 10+ production lines. Completion is targeted by Q4 FY2028 with full operations by Q2 FY2029.
- Execution
- Completion by Q4 FY2028; full operations by Q2 FY2029
- manufacturing production lines (injectable + oral solid + ophthalmic)
- 10 production lines
Kwality Pharmaceuticals Management Change
Kwality Pharmaceuticals has regularized the appointment of Mr. Swanith Kapoor as Independent Director and reappointed Mr. Aditya Arora as Whole Time Director for five years.
Kwality Pharmaceuticals Annual General Meeting
Kwality Pharmaceuticals Limited conducted its 43rd Annual General Meeting on August 31, 2026, via video conferencing. The meeting covered routine shareholder resolutions and director re-appointments.
Kwality Pharmaceuticals Earnings Call Transcript: Key Takeaways
Kwality Pharma Q1FY27 con-call highlights revision of FY27 revenue target to ₹700Cr+ with 26-27% EBITDA margins, driven by niche injectable registrations in LATAM and MENA regions.
- Call
- Guides 30% growth
Other board meeting date announcements
All →NMS Global Board Meeting Date
NMS Global scheduled a board meeting for November 14, 2026 to consider unaudited standalone and consolidated half-yearly financial results. Trading window stays closed until November 16, 2026.
Emmforce Autotech Board Meeting Date
Emmforce Autotech scheduled a board meeting for November 11, 2026 to consider unaudited half-year results. The trading window stays closed until November 13, 2026.
Oneclick Logistics Board Meeting Date
Oneclick Logistics India will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated half-year results for September 2026. The trading window is closed from 1 October to 15 November 2026.
Bhartiya International Board Meeting Date
Bhartiya International gave prior intimation of a board meeting on November 12, 2026 to consider unaudited quarterly results. The trading window stays closed until November 14, 2026.
Pramara Promotions Board Meeting Date
Pramara Promotions gave prior intimation of a board meeting to consider unaudited half-year results. The stated September 12, 2026 date predates this filing, suggesting a data error.
Liqvd Digital India Board Meeting Date
Liqvd Digital India Limited gave prior intimation of a board meeting on November 12, 2026 to consider unaudited standalone and consolidated half-year results. The trading window stays closed until 48 hours after the results are declared.